Among nonpregnant women of reproductive age in the US, the prevalence of chronic hypertension (cHTN) is approximately 9%, and hypertensive disorders of pregnancy complicate approximately 5% of all pregnancies.1 Although most pregnancies among individuals with well-controlled cHTN are uncomplicated, individuals with cHTN are at increased risk for maternal morbidity (eg, hypertensive urgency, preeclampsia, kidney failure, pulmonary edema, myocardial infarction, placental abruption, gestational diabetes, stroke, death) and poor fetal/neonatal outcomes (eg, growth restriction, preterm birth, congenital anomalies, stillbirth, perinatal death).1,2 Furthermore, cHTN during pregnancy increases long-term risks for development of cardiovascular, metabolic, and cerebrovascular disease.3 Therefore, effectively diagnosing and managing cHTN before, during, and after pregnancy is imperative for optimal maternal and child health.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Denise J. Jamieson, MD, MPH, Department of Gynecology and Obstetrics, Emory University School of Medicine, 101 Woodruff Cir, Woodruff Memorial Research Building, Ste 4208, Atlanta, GA 30322 (firstname.lastname@example.org).
Conflict of Interest Disclosures: Dr Badell reported receiving grants from the National Institutes of Health Chronic Hypertension and Pregnancy (CHAP) study site as a co-investigator during the conduct of the study. No other disclosures were reported.
You currently have no searches saved.
You currently have no courses saved.